NO20000827D0 - Human C3b/C4b-reseptor (CR1) - Google Patents

Human C3b/C4b-reseptor (CR1)

Info

Publication number
NO20000827D0
NO20000827D0 NO20000827A NO20000827A NO20000827D0 NO 20000827 D0 NO20000827 D0 NO 20000827D0 NO 20000827 A NO20000827 A NO 20000827A NO 20000827 A NO20000827 A NO 20000827A NO 20000827 D0 NO20000827 D0 NO 20000827D0
Authority
NO
Norway
Prior art keywords
fragments
expression
protein
secreted
proteins
Prior art date
Application number
NO20000827A
Other languages
English (en)
Other versions
NO315944B1 (no
NO20000827L (no
Inventor
Douglas T Fearon
Lloyd B Klickstein
Winnie W Wong
Gerald R Carson
Michael F Concino
Stephen H Ip
Savvas C Makrides
Jr Henry C Marsh
Original Assignee
Univ Johns Hopkins
Brigham & Womens Hospital
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20000827L publication Critical patent/NO20000827L/no
Application filed by Univ Johns Hopkins, Brigham & Womens Hospital, Avant Immunotherapeutics Inc filed Critical Univ Johns Hopkins
Publication of NO20000827D0 publication Critical patent/NO20000827D0/no
Publication of NO315944B1 publication Critical patent/NO315944B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20000827A 1988-04-01 2000-02-18 CR1 protein for diagnostisk anvendelse in vitro, dets nukleinsyresekvens, rekombinant celle uttrykkende CR1 proteinet og en fremgangsmåte forå rense et CR1 protein NO315944B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17653288A 1988-04-01 1988-04-01
PCT/US1989/001358 WO1989009220A1 (en) 1988-04-01 1989-03-31 THE HUMAN C3b/C4b RECEPTOR (CR1)
US41274589A 1989-09-26 1989-09-26

Publications (3)

Publication Number Publication Date
NO20000827L NO20000827L (no) 1990-11-09
NO20000827D0 true NO20000827D0 (no) 2000-02-18
NO315944B1 NO315944B1 (no) 2003-11-17

Family

ID=26872337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000827A NO315944B1 (no) 1988-04-01 2000-02-18 CR1 protein for diagnostisk anvendelse in vitro, dets nukleinsyresekvens, rekombinant celle uttrykkende CR1 proteinet og en fremgangsmåte forå rense et CR1 protein

Country Status (14)

Country Link
EP (1) EP0411031B1 (no)
JP (1) JP3484189B2 (no)
CN (2) CN1092712C (no)
AT (1) ATE240973T1 (no)
CA (2) CA1340866C (no)
DE (1) DE68929466T2 (no)
DK (1) DK175699B1 (no)
ES (1) ES2014593A6 (no)
FI (2) FI106316B (no)
IL (1) IL89790A (no)
NO (1) NO315944B1 (no)
SG (1) SG52789A1 (no)
WO (1) WO1989009220A1 (no)
ZA (2) ZA892397B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6482404B1 (en) 1989-10-12 2002-11-19 David James White Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
PT95580B (pt) 1989-10-12 1999-05-31 Imutran Ltd Processo para a preparacao de material biologico modificado
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US6458360B1 (en) * 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
CA2096418C (en) * 1990-11-26 2001-11-20 Philip J. Barr Expression of pace in host cells and methods of use thereof
CA2097825A1 (en) * 1990-12-06 1992-06-07 Henry C. Marsh, Jr. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
EP0512733A2 (en) 1991-05-03 1992-11-11 Washington University Modified complement system regulator
JP3939747B2 (ja) * 1992-06-24 2007-07-04 アドプロテック・リミテッド 可溶性ｃｒ１誘導体
US5456909A (en) * 1992-08-07 1995-10-10 T Cell Sciences, Inc. Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo
AU685433B2 (en) * 1993-02-12 1998-01-22 Regents Of The University Of Minnesota Pulmonary administration of sCR1 and other complement inhibitory proteins
AU734196B2 (en) 1996-03-28 2001-06-07 Whitehead Institute Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
GB9706950D0 (en) * 1997-04-05 1997-05-21 Chernajovsky Yuti Immune modulation by polypeptides related to CR1
US6664052B1 (en) 1998-07-24 2003-12-16 The Uab Research Foundation Genetic polymorphism in a complement receptor
WO2000005413A1 (en) * 1998-07-24 2000-02-03 Uab Research Foundation Genetic polymorphism in a complement receptor
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
EP1738763A1 (en) 2005-06-30 2007-01-03 AVANT Immunotherapeutics, Inc. Use of complement inhibitory proteins to treat spinal cord injury
PL2698166T3 (pl) 2006-10-10 2016-03-31 Regenesance B V Hamowanie układu dopełniacza służące do lepszej regeneracji nerwów
CA2744100C (en) 2008-10-21 2020-06-30 The General Hospital Corporation Cell transplantation
BR112013002859B1 (pt) 2010-08-06 2020-10-06 The General Hospital Corporation D/B/A Massachusetts General Hospital Método e aparelho para tratamento de células
CN103237557A (zh) 2010-09-15 2013-08-07 赛尔戴克斯治疗公司 用可溶性I型补体受体(sCR1)治疗慢性肾病
US9649356B2 (en) 2010-10-27 2017-05-16 Celldex Therapeutics, Inc. Method of improving transplant function using soluble complement receptor type I (sCR1)
AU2011332241B2 (en) * 2010-11-02 2015-11-26 Kypha, Inc. Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders
CN102702339B (zh) * 2011-05-24 2013-10-30 华南师范大学 斜带石斑鱼补体c3基因、载体、重组菌株和蛋白及其应用
DK2785744T3 (da) * 2011-12-01 2017-11-27 Innovent Biologics Inc Proteininhibitorer til komplement- og vegf-pathways og fremgangsmåder til anvendelse deraf
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN104293836A (zh) * 2014-06-24 2015-01-21 长沙赢润生物技术有限公司 一种免疫复合物吸附细胞的制作方法
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide
EP3760645A1 (en) * 2019-07-02 2021-01-06 imusyn GmbH & Co. KG Analysis for blood group antigen dacy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60192948A (ja) * 1984-03-14 1985-10-01 Fuji Photo Film Co Ltd 湿し水不要ネガ型感光性平版印刷版および製版方法
US4672044A (en) * 1984-08-24 1987-06-09 Scripps Clinic & Research Foundation Murine monoclonal antibody combining site to human C3b receptor (CR1)

Also Published As

Publication number Publication date
ZA892397B (en) 1989-11-29
DK234890A (da) 1990-11-30
IL89790A0 (en) 1989-09-28
CN1092712C (zh) 2002-10-16
CN1036987A (zh) 1989-11-08
DE68929466D1 (de) 2003-06-26
JPH04501502A (ja) 1992-03-19
SG52789A1 (en) 1998-09-28
DK234890D0 (da) 1990-09-28
DK175699B1 (da) 2005-01-24
NO315944B1 (no) 2003-11-17
CN1053265A (zh) 1991-07-24
IL89790A (en) 2002-05-23
EP0411031B1 (en) 2003-05-21
AU3539489A (en) 1989-10-16
FI20002515A (fi) 2000-11-16
NO20000827L (no) 1990-11-09
ES2014593A6 (es) 1990-07-16
ATE240973T1 (de) 2003-06-15
CA1341443C (en) 2003-10-07
JP3484189B2 (ja) 2004-01-06
CA1340866C (en) 1999-12-28
FI115528B (fi) 2005-05-31
EP0411031A4 (en) 1992-02-05
FI904842A0 (fi) 1990-10-01
EP0411031A1 (en) 1991-02-06
AU647371B2 (en) 1994-03-24
CN1053924C (zh) 2000-06-28
ZA907693B (en) 1992-05-27
WO1989009220A1 (en) 1989-10-05
FI106316B (fi) 2001-01-15
DE68929466T2 (de) 2004-04-01

Similar Documents

Publication Publication Date Title
ATE256181T1 (de) Menschlicher c3b/c4b-rezeptor (cr1)
DE68929466D1 (de) Menschlicher rezeptor c3b/c4b (cr1)
US5401651A (en) DNA encoding ENA-78, a neutrophil activating factor
HUT77578A (hu) A 10-es számú fibroblaszt növekedési faktor (FGF-10)
KR970705405A (ko) 사람 케모킨 폴리펩타이드(Human Chemokine Polypeptides)
BR9809914A (pt) Genes de moracella receptores de lactoferrina
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
MX9203654A (es) Purificacion, clonacion y caracterizacion del gen para la interleucina i.
JPH05503512A (ja) 白血球接着阻害因子としての［ａｌａ　ｉｌ―８］↓７↓７
ES2243942T3 (es) Isoforma intracelular del antagonista del receptor de la interleuquina.
PT98695A (pt) Gene codificador do factor neurotrofico de ligacao a heparina
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
PT83939B (pt) Metodo para a producao de factor angiogenico da placenta humana capaz de estimular a sintese de proteases, sintese de dna e migracao de celulas endoteliais capilares
EP0913470A3 (en) The human C3b/C4b receptor (CR1)
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
KR930701475A (ko) 사람의 거핵구-집락 촉진 인자(hMeg-CSF) 및 그것의 생산방법
BR0208140A (pt) Polipeptìdeo, agente imunoterapêutico para o tratamento de psorìase, sequência de ácido nucléico isolada ou seu complemento, vetores de filamento único, e de filamento duplo, sequência de ácido nucléico isolada ou variante imunogênica da mesma, métodos para a produção de polipeptìdeos, e para o tratamento e a remissão clìnica de psorìase, e, célula hospedeira microbiana
EP0308424A1 (en) A novel protein, neuroleukin

Legal Events

Date Code Title Description
MK1K Patent expired